Variant report
Variant | esv3449184 |
---|---|
Chromosome Location | chr5:29794985-29795480 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:6)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:6 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | EP300 | chr5:29795393-29795654 | Hela-S3 | cervix: | n/a | n/a |
2 | EP300 | chr5:29795198-29795813 | A549 | lung: | n/a | chr5:29795705-29795714 |
3 | GATA1 | chr5:29795340-29797051 | PBDE | blood: | n/a | chr5:29796378-29796387 chr5:29796684-29796695 chr5:29796004-29796025 |
4 | MAFF | chr5:29795379-29795721 | K562 | blood: | n/a | n/a |
5 | MAFK | chr5:29795451-29795725 | H1-hESC | embryonic stem cell: | n/a | chr5:29795703-29795712 chr5:29795705-29795715 |
6 | MAFK | chr5:29795377-29795698 | K562 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000250984 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs553370677 | chr5:29795012-29795013 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs374348156 | chr5:29795020-29795021 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs118174641 | chr5:29795107-29795108 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs531297050 | chr5:29795140-29795141 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs113871461 | chr5:29795150-29795151 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs75636191 | chr5:29795206-29795207 | Enhancers Flanking Active TSS Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs539029041 | chr5:29795207-29795208 | Enhancers Flanking Active TSS Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs551381665 | chr5:29795256-29795257 | Enhancers Flanking Active TSS Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs539358181 | chr5:29795273-29795274 | Enhancers Flanking Active TSS Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs149019034 | chr5:29795278-29795279 | Enhancers Flanking Active TSS Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs553612276 | chr5:29795284-29795285 | Enhancers Flanking Active TSS Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs574888152 | chr5:29795316-29795317 | Enhancers Flanking Active TSS Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs374381176 | chr5:29795334-29795335 | Enhancers Flanking Active TSS Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs16899413 | chr5:29795385-29795386 | Enhancers Flanking Active TSS Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs557139310 | chr5:29795403-29795404 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs575675234 | chr5:29795416-29795417 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Compulsive disorder | 18923513 | CNVD |
Epilepsy | 18923513 | CNVD |
Prader-willi syndrome | 18923513 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 20409316 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 19553991 | CNVD |
Lung cancer | 19553991 | CNVD |
Melanoma | 19553991 | CNVD |
Ovarian cancer | 19553991 | CNVD |
Prostate cancer | 19553991 | CNVD |
Non-small cell lung cancer | 17156491 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:29794200-29795000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr5:29794400-29795200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
3 | chr5:29794400-29796600 | Enhancers | A549 | lung |
4 | chr5:29794600-29796000 | Weak transcription | K562 | blood |
5 | chr5:29795000-29795400 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr5:29795000-29795400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
7 | chr5:29795000-29796600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
8 | chr5:29795000-29797000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
9 | chr5:29795200-29795600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
10 | chr5:29795200-29796000 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
11 | chr5:29795200-29796600 | Enhancers | Hela-S3 | cervix |
12 | chr5:29795400-29795800 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
13 | chr5:29795400-29796200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
14 | chr5:29795400-29796400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |